Prevalence of Coronary Artery Disease in the Siblings of Premature Coronary Heart Disease

July 20, 2012 updated by: Hyuk-Jae Chang, Yonsei University

Assessment of Occult CAD: Premature CAD Sibling Study (PreCASS)

The aim of this prospective study is to investigate the prevalence of coronary artery disease using computed tomography with family history of premature coronary heart disease

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

87

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Hyuk-Jae Chang, MD, PhD
  • Phone Number: 82-2-2228-8461
  • Email: hjchang@yuhs.ac

Study Locations

  • Korea, Republic of
      • Seoul, Korea, Republic of, 102-752
        • Recruiting
        • Yonsei University Severance Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

the siblings of premature coronary heart disease (male<55years old, female<65yeasrs old: Framingham Heart Study) patients admitted relevant hospital within 1 year

Description

Inclusion Criteria:

  • within 1 year
  • the siblings of premature coronary heart disease (male<55years old, female<65yeasrs old: Framingham Heart Study) patients admitted relevant hospital

Exclusion Criteria:

  • Documented coronary heart disease
  • experienced adverse events with relevant treatment
  • contraindicated with beta-blockers
  • Any woman of childbearing potential who is pregnant, seeking to become pregnant or suspects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
evaluation of prevalence to coronary artery disease using CT
Time Frame: within 2 weeks from CT scanning
within 2 weeks from CT scanning

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yonsei University

Collaborators

Korean Society of Lipidology and Atherosclerosis

Investigators

  • Principal Investigator: Hyuk-Jae Chang, MD, PhD, Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2009

Primary Completion (Anticipated)

September 1, 2012

Study Registration Dates

First Submitted

June 10, 2009

First Submitted That Met QC Criteria

June 10, 2009

First Posted (Estimate)

June 11, 2009

Study Record Updates

Last Update Posted (Estimate)

July 23, 2012

Last Update Submitted That Met QC Criteria

July 20, 2012

Last Verified

July 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20090616

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Heart Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe